Changing Aging Blogs
[Is your blog changing aging? Let us know at changingaging AT gmail DOT com]
- Ageless Marketing
- A Little Red Hen
- Better Than I Ever Expected
- Boomers
- Cab Drollery
- Duplex Planet
- EChronicles
- Ecumen's Changing Aging Blog
- EdlerAbuse.org
- Elder Law Issues
- Elder Storytelling Place
- Embodied Aging
- Global Ageing Network Blog
- Maya's Granny
- O'Folks
- Real Sage Advice
- Remembering Matters
- The Boomer Chronicles
- The Savvy Boomer
- The Story of Stuff
- Time Goes By
- Women's Voices for Change
Politics
- Daily Kos
- Grasping Reality
- The Huffington Post
- Talking Points Memo
- Think Progress
- The Washington Monthly
Media & Culture
- CJR Daily
- FAIR's Media Views
- FuturePundit
- Infomaniac: Behind the News
- Social Media
- Romenesko
- Truemors
Health & Science
News
Changing Aging Books
Search
Recent Posts
- ChangingAging.org Redesign -- Please Bookmark!
- Disaster in Buffalo
- Power Up Friday
- Blanchard WinsDays
- Kevin Frick writes...
- Monkhouse Monday
- Getting Closer!
- Blanchard WinsDays
- Power Up Friday
- My Pick for Health and Human Services
- Understanding Health Care Reform
- Facts Are Stubborn Things: Social Security Edition
- Monkhouse Monday
- Localism is Coming
- Krugman Can't Wait...
Recent Comments
- Dorothea Johnson on
Here We Go!
Category Archives
- AGING 100
- Aging
- Culture
- Dementia
- Eden Alternative
- Erickson School
- Green House
- Health Policy
- Longevity
- Media
- Rockets
Monthly Archives
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
Subscribe to this blog's feed
Blog Data
« Tis the Season | Main | Waste Not Want Not »
December 27, 2008 |Permalink |Comments (1)
Here We Go!
Allergan Inc., the company that makes Botox, announced on Friday that it has staked its claim in the eyelash enhancement market.
In a news release, the Irvine, Calif.-based company said it had received the U.S. Food and Drug Administration's blessing to market Latisse, the first prescription medication that makes lashes grow longer, thicker and darker. Once it reaches the market in March, annual sales of Latisse are expected to be somewhere in the neighborhood of $500 million.
A daily treatment, Latisse is applied to the base of the upper eyelid and the full effect is seen in 16 weeks. Once treatment is stopped, lashes will slowly return to normal, the company said in the release. The primary ingredient in Latisse, bimatoprost, is a prostaglandin analog that is present in hair and is thought to help in the development and regrowth of hair follicles. The company did warn that the medication should not be applied to the lower eyelid, and that any other part of the body that was exposed to Latisse might show hair growth. Allergan also noted that the eyelashes on each lid might not grow the exact same way.
Comments ( 1)
OMG! Blog readers should also know that prostaglandins have been used in prescription eye drops for a while now (Lumigan and Xalatan come to mind) as they are known to reduce intraocular pressures in the eye through increasing, what is known as, the aqueous humor) and therefore, treat open-angle glaucoma.
I see a trend here - the unscrupulous use of potent prescription drugs for cosmetic reasons by "taking advantage" of the drugs' side effects. Botox and Minoxidil are also an example of this lunacy.